drugset

drugset / Trial / NCT01145339

A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI)

NCT01145339 ↗

Phase 3 Completed 140 enrolled Eurofarma Laboratorios S.A.

RandomizedParallel-groupSingle-blindTreatment

Summary

The study primary objective is to compare the clinical efficacy of two formulations in the supportive treatment of lactose intolerance.

Timeline

Start: 2011-07
Primary completion: 2011-11
Completion: 2012-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	lactase	Protein / enzyme biologic	—	—

Indications